David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 150,000 shares at $0.19 ($29K) on 2016-03-09, disclosed to the SEC on 2016-03-09.
Open-market purchase of $28k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.19 | 50,000 | $10K | 33.3% |
| 2 | $0.19 | 100,000 | $19K | 66.7% |
| Total | $0.19 avg | 150,000 | $29K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |
| CYTX | BUY | 2015-08-20 | $19K | — | Filing → |